Lab Guide
A B C D E F
G H I J K L
M N O P Q R
S T U V W X
Y Z #

Test ID: VDRL Screen CSF
VDRL Antigen
Useful For

Qulitative and semi quantitative non-treponemal flocculation test for the detection of reagin antibodies in human CSF.

Method name and description

Slide agglutination

Reporting name

VDRL Screen CSF

Aliases

Neurosyphilis, Congenital syphilis

Specimen type / Specimen volume / Specimen container

Specimen type: CSF

Specimen volume: 1-2 mL

Specimen container: Sterile container

Collection instructions / Special Precautions / Timing of collection

C      Collection by lumbar puncture as per organization guidelines

No special precautions / No timing of collection

Storage and transport instructions

Maintain specimen at 2-8°C

The specimens should be transported to Virology Section in cold box immediately

Specimen Rejection Criteria

Quantity of sample not sufficient

Mixed with blood

Wrong container

Biological reference intervals and clinical decision values

Non-Reactive: Indicates that the sample tested does not contain reagin antibodies.

Reactive: Indicates that the sample tested contains reagin antibodies

Reactive with titer (e.g. 1:2; 1:4; 1:8; 1:16; 1:32), indicates the highest dilution that showed a reactive result.

Factors affecting test performance and result interpretation
  • Biological false-positive VDRL results may occur, particularly in individuals with drug abuse or conditions such as systemic lupus erythematosus (SLE), malaria, vaccinia, infectious mononucleosis, leprosy, viral pneumonia, and after smallpox vaccination.
  • Samples should be free from bacterial contamination, gross hemolysis or lipemia. 
  • Only CSF and serum is suitable for use in this test. Plasma is not acceptable.
  • Samples should be stored in the original tube at 2–8°C for up to 4 hours. For longer storage, the serum should be separated and stored at 2–8°C for up to 5 days or at –20°C for long-term storage.
  • Repeated freezing and thawing of specimens should be avoided.
  • A prozone effect may occur in samples with high antibody concentrations, causing weak or false-negative VDRL results; therefore, weakly reactive or nonreactive samples should be tested quantitatively to determine the true endpoint.
  • Pinta, yaws, bejel and other treponemal diseases produce positive reactions in this test.
  • The results of the VDRL Test must be confirmed by a treponemal test for reactive serum samples.
  • A final diagnosis should not be made on the result of a single test but should be based on a correlation of test results with other clinical findings.
Turnaround time / Days and times test performed / Specimen retention time

Turnaround time: within 48 hours

Days and times test performed: The sample is tested on the day of receipt or on the following day

Specimen retention time: 2 weeks.